Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2016

View Archived Issues

Two-antibody cocktail MIL77E protects primates from Ebola virus

NEOMED Institute announces partnership opportunities

EM Imaging and Mauna Kea enter clinical molecular imaging research collaboration

Researchers present novel murine models to study Zika virus

FDA grants orphan drug designation to ANAVEX 3-71 for frontotemporal dementia

Conference round-up: Biomarker studies from the USCAP Annual Meeting

MRC Technology and IPS-CAS enter antibody research agreement

FDA grants priority review to atezolizumab BLA in NSCLC

Bayer Schering Pharma discloses factor XIa kallikrein B inhibitors

Merck & Co. patents prolyl hydroxylase inhibitors

Shifa Biomedical reports endothelial lipase inhibitors

MedImmune reports antibodies linked to dimeric pyrrolobenzodiazepine

Helmsley Charitable Trust funds research into cell-based therapies for type 1 diabetes

Human Vaccines Project announces Mesa Consortium

Pritumumab receives FDA orphan drug designation for the treatment of pancreatic cancer

Somatostatin-dopamine chimeric compound demonstrates preclinical efficacy for acromegaly

Merck KGaA announces CE Mark approval for OncoBEAM RAS CRC test

FDA advisory committee set to review rociletinib NDA

MSD K.K. and Taiho sign copromotion agreement for pembrolizumab in Japan

Kyoto University and Sumitomo Dainippon Pharma launch second stage of DSK Project

4D pharma acquires Spanish company Instituto Biomar

FDA approves BromSite to prevent pain and treat inflammation following cataract surgery

EMA committee recommends that Alprolix maintains orphan drug designation

Addex Therapeutics announces results from dipraglurant clinical trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...